Correction to: Oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome

Tomoya Takemoto; Masayuki Baba; Kazumasa Yokoyama; Kohei Kitagawa; Kazuki Nagayasu; Yukio Ago; Kaoru Seiriki; Atsuko Hayata-Takano; Atsushi Kasai; Daisuke Mori; Norio Ozaki; Kazuhiro Takuma; Ryota Hashimoto; Hitoshi Hashimoto; Takanobu Nakazawa

doi:10.1186/s13041-022-00920-z

Correction to: Oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome

Mol Brain. 2022 Apr 11;15(1):34. doi: 10.1186/s13041-022-00920-z.

Authors

Tomoya Takemoto¹, Masayuki Baba¹, Kazumasa Yokoyama², Kohei Kitagawa¹, Kazuki Nagayasu^{1

3}, Yukio Ago⁴, Kaoru Seiriki^{1

5}, Atsuko Hayata-Takano^{1

6}, Atsushi Kasai¹, Daisuke Mori^{7

8}, Norio Ozaki⁷, Kazuhiro Takuma^{6

9}, Ryota Hashimoto¹⁰, Hitoshi Hashimoto^{11

12

13

14

15

16}, Takanobu Nakazawa^{17

18

19}

Affiliations

¹ Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan.
² Discovery Accelerator, Astellas Pharma Inc., Tsukuba-shi, Ibaraki, 305-8585, Japan.
³ Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.
⁴ Department of Cellular and Molecular Pharmacology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, 734-8553, Japan.
⁵ Interdisciplinary Program for Biomedical Sciences, Institute for Transdisciplinary Graduate Degree Programs, Osaka University, Suita, Osaka, 565-0871, Japan.
⁶ United Graduate School of Child Development, Molecular Research Center for Children's Mental Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, 565-0871, Japan.
⁷ Department of Psychiatry, Nagoya University Graduate School of Medicine, Nagoya, Aichi, 466-8550, Japan.
⁸ Brain and Mind Research Center, Nagoya University, Nagoya, Aichi, 466-8550, Japan.
⁹ Department of Pharmacology, Graduate School of Dentistry, Osaka University, Suita, Osaka, 565-0871, Japan.
¹⁰ Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 187-8553, Japan.
¹¹ Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
¹² United Graduate School of Child Development, Molecular Research Center for Children's Mental Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
¹³ Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 187-8553, Japan. hasimoto@phs.osaka-u.ac.jp.
¹⁴ Division of Bioscience, Institute for Datability Science, Osaka University, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
¹⁵ Transdimensional Life Imaging Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
¹⁶ Department of Molecular Pharmaceutical Science, Graduate School of Medicine, Osaka University, Suita, Osaka, 565-0871, Japan. hasimoto@phs.osaka-u.ac.jp.
¹⁷ Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka, 565-0871, Japan. tn207427@nodai.ac.jp.
¹⁸ Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo, 187-8553, Japan. tn207427@nodai.ac.jp.
¹⁹ Laboratory of Molecular Biology, Department of Bioscience, Graduate School of Life Sciences, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagaya-ku, Tokyo, 156-8502, Japan. tn207427@nodai.ac.jp.

No abstract available

Publication types

Published Erratum